BACKGROUND: Large animal models serve as a critical link in the translation of basic science to clinical practice. However, large animal models of myocardial infarction (MI), especially large size MI, have been associated with high mortality because of arrhythmia. The prophylactic effect of amiodarone and lidocaine were retrospectively reviewed in our ovine MI model. MATERIALS AND METHODS: A total of 114 Dorset hybrid sheep with 25%-30% MI were included in the present study. The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively. The sheep without prophylactic treatment (no prevention [NP] group, n = 20) were used as the control group. The incidence of arrhythmia requiring treatment, mortality due to arrhythmia, hemodynamics, and arterial blood gas values during surgery were analyzed in these three groups. RESULTS: No significant difference was found in infarct size among the three groups. The incidence of arrhythmia requiring treatment was significantly decreased in the AP group compared with that in the NP or SP groups (4.4% for AP versus 35% for NP and 45% for SP groups; P < 0.05). The mortality due to lethal arrhythmia was 2.2% in the AP group, significantly lower than that in the NP group (15%) or SP group (18.4%). Other than the heart rate, no significant differences were found in the hemodynamic data between the AP and NP groups. Metabolic acidosis was not observed in any group, as indicated by the pH and lactate values. CONCLUSIONS: Prophylactic amiodarone plus lidocaine decreased the mortality due to lethal arrhythmia after acute MI in our sheep model without significant negative effects on the hemodynamics. However, epinephrine improved the hemodynamics but also increased the mortality due to lethal arrhythmia. Thus, prophylactic amiodarone plus lidocaine is recommended to improve the stability in a large MI animal model.
BACKGROUND: Large animal models serve as a critical link in the translation of basic science to clinical practice. However, large animal models of myocardial infarction (MI), especially large size MI, have been associated with high mortality because of arrhythmia. The prophylactic effect of amiodarone and lidocaine were retrospectively reviewed in our ovine MI model. MATERIALS AND METHODS: A total of 114 Dorset hybrid sheep with 25%-30% MI were included in the present study. The sheep were prophylactically treated with amiodarone plus lidocaine before ligation of the four to six coronary artery branches supplying the apex of the heart (arrhythmia prevention [AP] group, n = 45) and with epinephrine (shock prevention [SP] group, n = 49), respectively. The sheep without prophylactic treatment (no prevention [NP] group, n = 20) were used as the control group. The incidence of arrhythmia requiring treatment, mortality due to arrhythmia, hemodynamics, and arterial blood gas values during surgery were analyzed in these three groups. RESULTS: No significant difference was found in infarct size among the three groups. The incidence of arrhythmia requiring treatment was significantly decreased in the AP group compared with that in the NP or SP groups (4.4% for AP versus 35% for NP and 45% for SP groups; P < 0.05). The mortality due to lethal arrhythmia was 2.2% in the AP group, significantly lower than that in the NP group (15%) or SP group (18.4%). Other than the heart rate, no significant differences were found in the hemodynamic data between the AP and NP groups. Metabolic acidosis was not observed in any group, as indicated by the pH and lactate values. CONCLUSIONS: Prophylactic amiodarone plus lidocaine decreased the mortality due to lethal arrhythmia after acute MI in our sheep model without significant negative effects on the hemodynamics. However, epinephrine improved the hemodynamics but also increased the mortality due to lethal arrhythmia. Thus, prophylactic amiodarone plus lidocaine is recommended to improve the stability in a large MI animal model.
Authors: Unto Häkkinen; Juha Hartikainen; Merja Juntunen; Antti Malmivaara; Mikko Peltola; Ilkka Tierala Journal: Ann Med Date: 2011-06 Impact factor: 4.709
Authors: Paul Dorian; Dan Cass; Brian Schwartz; Richard Cooper; Robert Gelaznikas; Aiala Barr Journal: N Engl J Med Date: 2002-03-21 Impact factor: 91.245
Authors: B A Weinberg; W M Miles; L S Klein; J E Bolander; R E Dusman; M S Stanton; J J Heger; C Langefeld; D P Zipes Journal: Am Heart J Date: 1993-01 Impact factor: 4.749
Authors: Patrick J Morrissey; Kevin R Murphy; Jean M Daley; Lorraine Schofield; Nilufer N Turan; Karuppiah Arunachalam; J Dawn Abbott; Gideon Koren Journal: Am J Physiol Heart Circ Physiol Date: 2017-02-17 Impact factor: 4.733
Authors: Stefan M Sattler; Anniek F Lubberding; Lasse Skibsbye; Reza Jabbari; Reza Wakili; Thomas Jespersen; Jacob Tfelt-Hansen Journal: J Cardiovasc Transl Res Date: 2019-01-07 Impact factor: 4.132
Authors: Stefan Michael Sattler; Lasse Skibsbye; Dominik Linz; Anniek Frederike Lubberding; Jacob Tfelt-Hansen; Thomas Jespersen Journal: Front Cardiovasc Med Date: 2019-11-05
Authors: Louise E See Hoe; Karin Wildi; Nchafatso G Obonyo; Nicole Bartnikowski; Charles McDonald; Kei Sato; Silver Heinsar; Sanne Engkilde-Pedersen; Sara Diab; Margaret R Passmore; Matthew A Wells; Ai-Ching Boon; Arlanna Esguerra; David G Platts; Lynnette James; Mahe Bouquet; Kieran Hyslop; Tristan Shuker; Carmen Ainola; Sebastiano M Colombo; Emily S Wilson; Jonathan E Millar; Maximillian V Malfertheiner; Janice D Reid; Hollier O'Neill; Samantha Livingstone; Gabriella Abbate; Noriko Sato; Ting He; Viktor von Bahr; Sacha Rozencwajg; Liam Byrne; Leticia P Pimenta; Lachlan Marshall; Lawrie Nair; John-Paul Tung; Jonathan Chan; Haris Haqqani; Peter Molenaar; Gianluigi Li Bassi; Jacky Y Suen; David C McGiffin; John F Fraser Journal: Intensive Care Med Exp Date: 2021-12-24